These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6831430

  • 21. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.
    Fidler IJ, Fogler WE, Brownbill AF, Schumann G.
    J Immunol; 1987 Jun 15; 138(12):4509-14. PubMed ID: 3584979
    [Abstract] [Full Text] [Related]

  • 22. Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma.
    Fidler IJ, Jessup JM, Fogler WE, Staerkel R, Mazumder A.
    Cancer Res; 1986 Feb 15; 46(2):994-8. PubMed ID: 3000591
    [Abstract] [Full Text] [Related]

  • 23. Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
    Talmadge JE, Schneider M, Collins M, Phillips H, Herberman RB, Wiltrout RH.
    J Immunol; 1985 Aug 15; 135(2):1477-83. PubMed ID: 4008928
    [Abstract] [Full Text] [Related]

  • 24. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES.
    Hematol Oncol Clin North Am; 1995 Aug 15; 9(4):927-38. PubMed ID: 7490249
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma.
    Kleinerman ES, Snyder JS, Jaffe N.
    J Clin Oncol; 1991 Feb 15; 9(2):259-67. PubMed ID: 1988574
    [Abstract] [Full Text] [Related]

  • 28. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
    Sone S, Lopez-Berestein G, Fidler IJ.
    J Natl Cancer Inst; 1985 Mar 15; 74(3):583-90. PubMed ID: 3856062
    [Abstract] [Full Text] [Related]

  • 29. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul 15; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 30. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
    Lopez-Berestein G, Mehta K, Mehta R, Juliano RL, Hersh EM.
    J Immunol; 1983 Apr 15; 130(4):1500-2. PubMed ID: 6300230
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC, Rioux J, Tsao MS.
    Hepatology; 1988 Apr 15; 8(5):1046-50. PubMed ID: 2971013
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
    Merhi G, Coleman AW, Devissaguet JP, Barratt GM.
    J Med Chem; 1996 Oct 25; 39(22):4483-8. PubMed ID: 8893843
    [Abstract] [Full Text] [Related]

  • 34. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S, Tsubura E.
    J Immunol; 1982 Sep 25; 129(3):1313-7. PubMed ID: 7108208
    [Abstract] [Full Text] [Related]

  • 35. Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma.
    Fidler IJ, Fan D, Ichinose Y.
    Invasion Metastasis; 1989 Sep 25; 9(2):75-88. PubMed ID: 2496047
    [Abstract] [Full Text] [Related]

  • 36. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan 25; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 37. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
    Eue I, Kumar R, Dong Z, Killion JJ, Fidler IJ.
    J Immunother; 1998 Sep 25; 21(5):340-51. PubMed ID: 9789196
    [Abstract] [Full Text] [Related]

  • 38. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec 25; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 39. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
    Ichinose Y, Bakouche O, Tsao JY, Fidler IJ.
    J Immunol; 1988 Jul 15; 141(2):512-8. PubMed ID: 3260254
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.